Skip to main content
. 2020 May 7;20:106. doi: 10.1186/s12871-020-01022-w

Table 2.

Univariate comparison of demographics and clinical characteristics for study cohort

Blood Glucose <= 180 (N = 3600) n(%) Blood Glucose > 180 (N = 1414) n(%) P-value
Patient Demographics
 Age 66.0 [57.0 to 74.0] 65.0 [56.0 to 72.0] 0.003
WHO BMI Classification < 0.001
  Underweight 75 (2.1) 23 (1.6)
  Normal 818 (22.7) 232 (16.4)
  Overweight 1063 (29.5) 366 (25.9)
  Obese 1644 (45.7) 793 (56.1)
 Female Gender 1628 (45.2) 677 (47.9) 0.090
 ASA Class 3 or 4 3184 (88.4) 1265 (89.5) 0.305
 Urgent/Emergent Case 1334 (37.1) 540 (38.2) 0.455
Surgical Procedure Group 0.011
  General 539 (15.0) 201 (14.2)
  Endocrine 279 (7.8) 131 (9.3)
  Hepatobiliary 382 (10.6) 178 (12.6)
  GI (Upper and Colorectal) 1162 (32.3) 478 (33.8)
  Vascular 1238 (34.4) 426 (30.1)
Pre-operative Clinical Characteristics
Pre-op Sepsis 0.005
  None 3293 (91.5) 1267 (89.6)
  Sepsis 145 (4.0) 87 (6.2)
  Severe Sepsis 162 (4.5) 60 (4.2)
 Diabetes 2151 (59.8) 1080 (76.4) < 0.001
 Sleep Apnea 729 (20.3) 332 (23.5) 0.012
 Cancer 156 (4.3) 56 (4.0) 0.555
 CHF 87 (2.4) 25 (1.8) 0.162
 COPD 574 (15.9) 216 (15.3) 0.559
 CAD 1270 (35.3) 452 (32.0) 0.026
 DVT/PEa 392 (11.4) 150 (11.0) 0.711
 ETOH > 2 drinks/day in the 2 weeks prior to admission 113 (3.1) 32 (2.3) 0.096
 Tobacco use within 1 year - cigarette 1011 (28.1) 356 (25.2) 0.038
 Hypertension 2708 (75.2) 1123 (79.4) 0.002
 Pneumonia 53 (1.5) 27 (1.9) 0.266
 HbA1ca 6.9 [6.1 to 8.2] 8.0 [6.9 to 9.6] < 0.001
 Creatininea 0.9 [0.7 to 1.2] 0.9 [0.7 to 1.3] 0.313
 Ascites 77 (2.1) 21 (1.5) 0.132
 10% Loss of Body Weight 6 Months Before Surgery 148 (4.1) 55 (3.9) 0.720
 Steroids/Immunosuppressive Meds for chronic condition 220 (6.1) 84 (5.9) 0.820
 Currently Requires or is on Dialysis 184 (5.1) 39 (2.8) < 0.001
 Open Wound With or Without Infection 502 (13.9) 155 (11.0) 0.005
 Peripheral Vascular Disease 839 (23.3) 330 (23.3) 0.981
 Ventilator Dependent 67 (1.9) 29 (2.1) 0.659
Intraoperative Characteristics
 Surgical Time (Minutes) 149.0 [95.0 to 237.0] 185.5 [107.0 to 288.0] < 0.001
 Insulin Given 239 (6.6) 788 (55.7) < 0.001
Outcomes
 30 Day Morbidity and Mortalitya 1109 (30.9) 538 (38.1) < 0.001
 Infectious Complications 622 (17.3) 287 (20.3) 0.013

Data are presented as frequency (%) or median [25th percentile to 75th percentile], as appropriate

aPercentages for diabetic/non-diabetic are given as percent of the non-missing number of values in that group